Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prickle planar cell polarity protein 1 (PRICKLE1) is a protein encoded by the PRICKLE1 gene in humans. It is involved in the planar cell polarity pathway, which is crucial for controlling the organization and movement of cells during development. PRICKLE1 functions as a negative regulator of the canonical Wnt/beta-catenin signaling pathway and plays a role in the localization and trafficking of transcriptional repressors such as REST/NRSF. The protein is essential for proper nervous system development, specifically for neuronal migration and cell polarity, and is required for normal limb and neural tube development. Mutations in PRICKLE1 are linked to progressive myoclonus epilepsy and associated neurological symptoms, highlighting its critical role in neurodevelopment[1][2][3][4]. Note: - PRICKLE1 is not a classical therapeutic target such as an enzyme, receptor, transporter, or ion channel, thus "is_target: false". - There are currently no known small molecule drugs or approved therapeutics that directly target PRICKLE1, so "interacting_drugs", "mechanism_of_action", and "biomarkers" are returned as null[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prickle planar cell polarity protein 1 (PRICKLE1).